“Valeant Doesn’t Look Cheap” – Barron’s

barron's
Share with your friends










Submit

Over the weekend, Barron’s magazine featured our research for the fourth time in 2016 and 20th time since 2014. This time, Barron’s featured our research on Valeant Pharmaceuticals (VRX).

See the Barron’s article here.

In addition, you can see all our media coverage here.

Leave A Response

* Denotes Required Field